The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Severe Hypoglycemia and Risks of Vascular Events and Death
Open accessAbstract
BACKGROUND: Severe hypoglycemia may increase the risk of a poor outcome in patients with type 2 diabetes assigned to an intensive glucose-lowering intervention. We analyzed data from a large study of intensive glucose lowering to explore the relationship between severe hypoglycemia and adverse clinical outcomes. METHODS: We examined the associations between severe hypoglycemia and the risks of macrovascular or microvascular events and death among 11,140 patients with type 2 diabetes, using Cox proportional-hazards models with adjustment for covariates measured at baseline and after randomization. RESULTS: During a median follow-up period of 5 years, 231 patients (2.1%) had at least one severe hypoglycemic episode; 150 had been assigned to intensive glucose control (2.7% of the 5571 patients in that group), and 81 had been assigned to standard glucose control (1.5% of the 5569 patients in that group). The median times from the onset of severe hypoglycemia to the first major macrovascular event, the first major microvascular event, and death were 1.56 years (interquartile range, 0.84 to 2.41), 0.99 years (interquartile range, 0.40 to 2.17), and 1.05 years (interquartile range, 0.34 to 2.41), respectively. During follow-up, severe hypoglycemia was associated with a significant increase in the adjusted risks of major macrovascular events (hazard ratio, 2.88; 95% confidence interval [CI], 2.01 to 4.12), major microvascular events (hazard ratio, 1.81; 95% CI, 1.19 to 2.74), death from a cardiovascular cause (hazard ratio, 2.68; 95% CI, 1.72 to 4.19), and death from any cause (hazard ratio, 2.69; 95% CI, 1.97 to 3.67) (P<0.001 for all comparisons). Similar associations were apparent for a range of nonvascular outcomes, including respiratory, digestive, and skin conditions (P<0.01 for all comparisons). No relationship was found between repeated episodes of severe hypoglycemia and vascular outcomes or death. CONCLUSIONS: Severe hypoglycemia was strongly associated with increased risks of a range of adverse clinical outcomes. It is possible that severe hypoglycemia contributes to adverse outcomes, but these analyses indicate that hypoglycemia is just as likely to be a marker of vulnerability to such events. (Funded by Servier and the National Health and Medical Research Council of Australia; ClinicalTrials.gov number, NCT00145925.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the frequency of severe hypoglycemia in these trials was 2 to 3 times higher in the intensive therapy groups”
From Targets for Glycemic Control (2018) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with type 2 diabetes and established, or very high risk for, cardiovascular disease (CVD), there is a clear association between an increased mortality and severe hypoglycemia (62,63) and symptomatic hypoglycemia (64).”
From Hypoglycemia (2018) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Post hoc analysis of clinical trials examining the effects of strict glycemic control on cardiovascular outcomes showed that exposure to severe hypoglycemia was strongly associated with a range of adverse outcomes, including death (2, 3).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
The cited source says what the claim attributes to it.
In the citing paper
“a higher mortality was reported in participants with 1 or more episodes of severe hypoglycemia in the ACCORD (30), ADVANCE (31) and VADT trials (25), irrespective of the different treatment arms in which individual participants were allocated.”
From Targets for Glycemic Control (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [77]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“U500 regular insulin (contains 500 units/mL of regular insulin) may improve glycemia in the therapy of persons with DM who have severe insulin resistance (eg, require >200 total units of insulin/day).1102–1105”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1105]
Experimental — accuracy not yet measuredIn the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [197]
In the citing paper
“All three trials clearly demonstrated that an episode of severe hypoglycemia was associated with an increased risk of subsequent mortality.”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [47]
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial (90).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Rovere, M. T. L., Bigger, J. T., Marcus, F. I., Mortara, A., & Schwartz, P. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11144-8 · Cited by 3,120
Patel, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61303-8 · Cited by 2,054
Self-citationIntensive glucose control and macrovascular outcomes in type 2 diabetes
Turnbull, F. M., Abraira, C., Anderson, R. J., Byington, R. P., Chalmers, J. P., Duckworth, W. C., Evans, G. W., Gerstein, H. C., Holman, R. R., Moritz, T. E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1470-0 · Cited by 1,189
Self-citationGerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Flagged first, then by citations
Research works printed but not linked: 3
- Therneau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York: Springer, 2000.
- Hoekstra JBL, 2009, Diabetologia, 52, 237
- Miller ME, 2009, Diabetologia, 52, 63
Cited by
Sorted by citations
Items 701–800 of 1,002
Okajima, F., Nagamine, T., Nakamura, Y., Hattori, N., Sugihara, H., & Emoto, N. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12588 · Cited by 14
New risk and protective factors for severe hypoglycaemia in people with type 1 diabetes
Wohland, T., Holstein, J. D., Patzer, O. M., Mende, M., Tiemann, T., Koch-Tessarek, C., Kovacs, P. L., & Holstein, A. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.12.006 · Cited by 14
Korytkowski, M. T., & Forman, D. E. (2017) · Diabetes Care · doi:10.2337/dc16-0815 · Cited by 14
He, F., Shu, Y., Wang, X., Liu, X., Liu, G., Chen, Z., Wang, Z., Li, L., Liu, R., Zhou, H.-H., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01422 · Cited by 14
Lo, S., Yang, Y., Kornelius, E., Huang, J., Lai, Y., Huang, C., & Chiou, J. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13746 · Cited by 14
Villani, M., Earnest, A., Smith, K. L., Giannopoulos, D., Soldatos, G., de Courten, B. V., & Zoungas, S. (2019) · Diabetologia · doi:10.1007/s00125-019-4933-y · Cited by 14
Self-citationRisk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE
Heller, S. R., Lingvay, I., Marso, S. P., Philis‐Tsimikas, A., Pieber, T. R., Poulter, N. R., Pratley, R. E., HACHMANN-NIELSEN, E., Kvist, K., Lange, M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14049 · Cited by 14
Self-citationRegulation of Gluconeogenesis by Aldo-keto-reductase 1a1b in Zebrafish
Li, X., Schmöhl, F., Qi, H., Bennewitz, K., Tabler, C. T., Poschet, G., Hell, R., Volk, N., Poth, T., Haußer, I., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101763 · Cited by 14
Lee, S., Ock, M., Kim, H., & Kim, H. (2020) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2450 · Cited by 13
Escalada, J., Liao, L., Pan, C., Wang, H., & BALA, M. M. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1189893 · Cited by 13
Kawaguchi, Y., Sawa, J., & Kumeda, Y. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00940-9 · Cited by 13
Washed microbiota transplantation reduces glycemic variability in unstable diabetes
Li, Y., Liu, Q., Zhang, L., Zou, J., He, R., Zhou, Y., Chen, Q., Zhu, Y., Chen, R., Zhang, Y., et al. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13485 · Cited by 13
Yıldırım, D., Yıldız, C. Ç., Ergin, E., & Özbay, İ. (2024) · International Journal of Nursing Practice · doi:10.1111/ijn.13248 · Cited by 13
Lingvay, I., Bache, J. K., Desouza, C. V., Fragão-Marques, M., Navarria, A., Shaikh, S. S., & Vianna, A. G. D. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf168 · Cited by 13
Huelgas, R. G., Peralta, F. G., Fernández, L. C., Galve, E., Casanueva, F. F., Puig‐Domingo, M., Bravo, J. J. M., Orozco‐Beltrán, D., Muñoz, J. E., Torre, E. L. M., et al. (2015) · Revista Clínica Española · doi:10.1016/j.rce.2015.07.003 · Cited by 13
Kurozumi, A., Okada, Y., Mori, H., Arao, T., & Tanaka, Y. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12059 · Cited by 13
Mita, T., Katakami, N., Shiraiwa, T., Yoshii, H., Kuribayashi, N., Osonoi, T., Kaneto, H., Kosugi, K., Umayahara, Y., Gosho, M., et al. (2017) · Scientific Reports · doi:10.1038/srep39965 · Cited by 13
Kaewput, W., Thongprayoon, C., Rangsin, R., Bathini, T. J., Torres‐Ortiz, A., Mao, M. A., & Cheungpasitporn, W. (2020) · Endocrine Research · doi:10.1080/07435800.2020.1792921 · Cited by 13
Koracevic, G. P., Mićić, S., Stojanović, M., Tomasevic, M. V., Kostić, T. L., Koraćević, M., & Janković, I. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.09.004 · Cited by 14
van Wilpe, R., Hulst, A. H., Siegelaar, S. E., DeVries, J. H., Preckel, B., & Hermanides, J. (2022) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2022.111012 · Cited by 13
Shibamoto, J., Kubota, T., Nishibeppu, K., Ohashi, T., Konishi, H., Shiozaki, A., Fujiwara, H., & Otsuji, E. (2023) · Anticancer Research · doi:10.21873/anticanres.16228 · Cited by 13
Klimontov, V. V., Tsiberkin, A. I., Fazullina, O. N., Александровна, П. М., Tyan, N. V., & Konenkov, V. I. (2014) · Diabetes Mellitus · doi:10.14341/dm2014175-80 · Cited by 13
Tsujimoto, T., Yamamoto‐Honda, R., Kajio, H., Kishimoto, M., Noto, H., Hachiya, R., Kimura, A., Kakei, M., & Noda, M. (2015) · Medicine · doi:10.1097/md.0000000000001629 · Cited by 13
Terauchi, Y., Ozaki, A., Zhao, X., Teoh, C., Jaffe, D., Tajima, Y., & Shuto, Y. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.01.019 · Cited by 13
Tiruneh, G. G., Abebe, N., & Dessie, G. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0341-z · Cited by 13
Saulnier, P., Briet, C., Gand, E., Chaillous, L., Dubois, S. G., Bonnet, F., Leguerrier, A.-M., Fradet, G., Crespin, I. D., Kerlan, V., et al. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.05.003 · Cited by 13
He, H., Zhang, Y., Zhao, D., Jiang, J., Xie, B., Ma, L., Liu, X., & Yu, C. (2020) · Xenobiotica · doi:10.1080/00498254.2020.1734882 · Cited by 13
Hypoglycemia, Malnutrition and Body Composition
Khanimov, I., Shimonov, M., Wainstein, J., & Leibovitz, E. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_526 · Cited by 13
Camerlingo, N., Vettoretti, M., Facchinetti, A., Sparacino, G., Mader, J. K., Choudhary, P., & Favero, S. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-75079-5 · Cited by 13
Zhao, M., Prentice, J. C., Mohr, D. C., & Conlin, P. R. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001797 · Cited by 14
Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes
Lajara, R. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.741591 · Cited by 13
Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies
Pistrosch, F., & Hanefeld, M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0678-2 · Cited by 13
Lega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
High concurrent use of sulfonylureas and antimicrobials with drug interactions causing hypoglycemia
Pilla, S. J., Pitts, S. I., & Maruthur, N. M. (2022) · Journal of Patient Safety · doi:10.1097/pts.0000000000000739 · Cited by 12
Tschöpe, D., Bramlage, P., Schneider, S., & Gitt, A. K. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164115610470 · Cited by 12
Hasslacher, C., & Bermejo, J. L. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018817732732 · Cited by 12
Yang, T., Ziemba, R. E., Shehab, N., Geller, A. I., Talreja, K., Campbell, K. N., & Budnitz, D. S. (2022) · Medical Care · doi:10.1097/mlr.0000000000001682 · Cited by 12
Bedtime Prediction of Nocturnal Hypoglycemia in Insulin-Treated Type 2 Diabetes Patients
Kronborg, T., Hangaard, S., Hejlesen, O. K., Vestergaard, P., & Jensen, M. H. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221141736 · Cited by 12
Chen, S., Tian, P., Estau, D., & Li, Z. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1076107 · Cited by 12
Cho, S., Kim, C. O., Soo, B., Kim, E., Nam, C. M., Kim, M., & Park, M. S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110721 · Cited by 12
Aktuelle Therapie des Typ-2-Diabetes
Schernthaner, G., & Schernthaner, G.-H. (2012) · Der Internist · doi:10.1007/s00108-012-3203-6 · Cited by 12
The impact of severe hypoglycemia on renal impairment in type 2 diabetes
Lee, Y.-L., Chen, B., Lin, K., Su, R.-W., Lee, M., Hsiao, P., & Shin, S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.028 · Cited by 15
Pollock, R. F., Valentine, W. J., Marso, S. P., Gundgaard, J., Hallén, N., Hansen, L., Tutkunkardas, D., Buse, J. B., & On behalf of the DEVOTE Study Group (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0430-4 · Cited by 12
Hulst, A. H., Polderman, J. A. W., Kooij, F. O., Vittali, D., Lirk, P. B., Hollmann, M. W., DeVries, J. H., Preckel, B., & Hermanides, J. (2018) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13274 · Cited by 12
Kaneto, H., Koshida, R., & Baxter, M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14095 · Cited by 12
Lai, J., Wang, M., Wu, C., Huang, Y., Lu, C., & Liou, J. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5034 · Cited by 12
Monnier, L., Colette, C., & Owens, D. R. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.06.004 · Cited by 12
Potential Risk of Hypoglycemia in Patients with Heart Failure
Teshima, Y., Shiga, R., Saito, S., Kondo, H., Fukui, A., Fukuda, T., Okada, N., Akioka, H., Shinohara, T., Akiyoshi, K., et al. (2020) · International Heart Journal · doi:10.1536/ihj.20-134 · Cited by 12
Hunt, L. M., Arndt, E., Bell, H. S., & Howard, H. (2021) · Journal of Bioethical Inquiry · doi:10.1007/s11673-021-10119-x · Cited by 12
Changes in blood glucose and lactate concentrations with hemodialysis
Watha, K., Davenport, A., & Tangvoraphonkchai, K. (2021) · Artificial Organs · doi:10.1111/aor.14097 · Cited by 12
Frequency of Hypoglycemia Assessed by Continuous Glucose Monitoring in Advanced CKD
Ushiogi, Y., Kanehara, H., & Kato, T. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000102 · Cited by 12
Bariatric surgery and diabetes: Current challenges and perspectives
He, Y., Hu, X.-D., Liu, J., Li, H., & Lu, S.-F. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i8.1692 · Cited by 12
Samuel, S., Goswami, D., Shum, K., Boye, K. S., Rengarajan, B., Curtis, B. H., & Curtis, S. E. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1020363 · Cited by 13
Odawara, M., Kadowaki, T., & Naito, Y. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.09.012 · Cited by 12
Hypoglycaemia, a global cause for concern
Heller, S. R., Amiel, S. A., & Khunti, K. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.11.004 · Cited by 12
Self-citationRauh, S. P., Rutters, F., Thorsted, B. L., Wolden, M. L., Nijpels, G., van der Heijden, A. A. W. A., Walraven, I., Elders, P. J. M., Heymans, M. W., & Dekker, J. M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012793 · Cited by 12
Dalbhi, S. A., ALEissa, M., ALGHOFAILI, I. A., Alotaibi, H. F., Yaslam, M., AlMujil, M., & Arnous, M. M. (2020) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_304_19 · Cited by 12
Ohkuma, T., Chalmers, J. P., Cooper, M. E., Hamet, P., Harrap, S. B., Marre, M., Mancia, G., Poulter, N. R., & Woodward, M. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14339 · Cited by 12
Self-citationFox, I., Ang, L. P., Jaiswal, M., Pop‐Busui, R., & Wiens, J. (2017) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/3097983.3098068 · Cited by 12
Optimizing glycemic control and minimizing the risk of hypoglycemia in patients with type 2 diabetes
Schwartz, S. J. (2013) · Drugs in Context · doi:10.7573/dic.212255 · Cited by 12
Educating Patients About Hypoglycemia Prevention and Self-Management
Unger, J. (2013) · Clinical Diabetes · doi:10.2337/diaclin.31.4.179 · Cited by 12
Study of glucose concentration influence on blood optical properties in THz frequency range
Gusev, S. I., Demchenko, P., Litvinov, E. A., Черкасова, О. П., Meglinski, I. V., & Khodzitsky, M. K. (2018) · Nanosystems Physics Chemistry Mathematics · doi:10.17586/2220-8054-2018-9-3-389-400 · Cited by 12
Cardiovascular Safety of Antihyperglycemic Agents: “Do Good or Do No Harm”
Manolis, A. S., Manolis, T. A., & Manolis, A. S. (2018) · Drugs · doi:10.1007/s40265-018-0985-4 · Cited by 12
Management of chronic kidney disease
Tomson, C., & Taylor, D. M. (2015) · Medicine · doi:10.1016/j.mpmed.2015.05.004 · Cited by 13
Davis, W. A., Brown, S. G. A., Jacobs, I. G., Bulsara, M. K., Beilby, J. P., Bruce, D. G., & Davis, T. M. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2087 · Cited by 12
Intensive glucose lowering treatment in type 2 diabetes
Preiss, D., & Ray, K. K. (2011) · BMJ · doi:10.1136/bmj.d4243 · Cited by 14
Devoting attention to glucose variability and hypoglycaemia in type 2 diabetes
Rutter, M. K. (2017) · Diabetologia · doi:10.1007/s00125-017-4421-1 · Cited by 14
Insulin murder and the case of Colin Norris
Jones, A. W. (2023) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2023.102483 · Cited by 13
Glycaemia and cardiac arrhythmias in people with type 1 diabetes: A prospective observational study
Hagelqvist, P. G., Andersen, A., Maytham, K. B., Andreasen, C. R., Engberg, S., Lindhardt, T. B., Forman, J. L., Pedersen‐Bjergaard, U., Knop, F. K., & Vilsbøll, T. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15108 · Cited by 11
Abe, M., Hatta, T., Imamura, Y., Sakurada, T., & Kaname, S. (2023) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.026 · Cited by 11
Hypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality
González‐Vidal, T., Lambert, C., García, A. V., Villa-Fernández, E., Pujante, P., Ares, J., Torre, E. L. M., & Delgado, E. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01329-5 · Cited by 12
DeVries, J. H., Meneghini, L., Barnett, A. H., Reid, T., Dain, M., Sanofi, P., Landgraf, W., Vlajnic, A., Traylor, L., & Bergenstal, R. M. (2014) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2014.10.01.23 · Cited by 11
Floyd, J. S., Wiggins, K. L., Christiansen, M. W., Dublin, S., Longstreth, W. T., Jr., Smith, N. L., McKnight, B., Heckbert, S. R., Weiss, N. S., & Psaty, B. M. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3914 · Cited by 11
BRUGINSKI, D., Précoma, D. B., Sabbag, A. E., & Olandowski, M. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815999190619141622 · Cited by 11
Myers, L. A., Swanson, K. M., Glasgow, A. E., & McCoy, R. G. (2022) · Diabetes Care · doi:10.2337/dc21-1811 · Cited by 11
Fan, Y., Lau, E. S. H., Wu, H., Yang, A., Chow, E., Kong, A. P. S., Ronald, C. W., Chan, J. C. N., & Luk, A. O. Y. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100730 · Cited by 11
Nakajima, K., Mita, T., Osonoi, Y., Azuma, K., Takasu, T., Fujitani, Y., & Watada, H. (2015) · International Journal of Endocrinology · doi:10.1155/2015/406394 · Cited by 11
Blood electrolyte disturbances during severe hypoglycemia in Korean patients with type 2 diabetes
Kang, M. Y. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.5.648 · Cited by 11
Overview of the Guidelines and Evidence for the Pharmacologic Management of Type 2 Diabetes Mellitus
Liday, C. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.12.37s · Cited by 11
Safety of Rapid-Acting Insulin Analogs Versus Regular Human Insulin
Kitabchi, A. E., & Gosmanov, A. R. (2012) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182449ff9 · Cited by 11
Solomon, M. D., Vijan, S. S., Forma, F. M., Conrad, R. M., Summers, N., & Lakdawalla, D. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.013 · Cited by 11
Hypoglycemia unawareness prevention: Targeting glucagon production
Samson, W. K., Stein, L. M., Elrick, M. M., Salvatori, A., Kolar, G. R., Corbett, J. A., & Yosten, G. L. C. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.04.012 · Cited by 11
Optimizing management of glycaemia
Chatterjee, S., Khunti, K., & Davies, M. J. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.002 · Cited by 11
Matsunaga, S., Tanaka, S., Fujihara, K., Horikawa, C., Iimuro, S., Kitaoka, M., Sato, A., Nakamura, J., Haneda, M., Shimano, H., et al. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.05.020 · Cited by 11
Huang, W. Q., Guo, J. H., Yuan, C., Cui, Y. G., Diao, F., Yu, M., Liu, J. Y., Ruan, Y. C., & Chan, H. C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00835 · Cited by 11
Balkau, B., Metzger, M., Andréelli, F., Frimat, L., Speyer, É., Combe, C., Laville, M., Jacquelinet, C., Briançon, S., Ayav, C., et al. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.03.007 · Cited by 11
Dissanayake, H. A., Keerthisena, G. S. P., Gamage, K. K. K., Liyanage, J. H., Ihalagama, I. R. H. S., Wijetunga, W. M. U. A., Tillekaratne, T. A. D., Katulanda, G. W., & Katulanda, P. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0264-0 · Cited by 12
Chen, Y.-Y., Chen, Y., Liang, S.-M., Su, Z.-Z., Shu, X., Zhang, H.-F., Wan, S., Wang, J.-F., & Xie, S.-L. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.239310 · Cited by 11
Ikeda, Y., Kubo, T., Oda, E., Abe, M., & Tokita, S. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12959 · Cited by 11
Lee, Y.-L., Yen, S., Shin, S., Huang, Y.-C., He, J. S., & Lin, K. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16050681 · Cited by 12
He, X., Yang, Y., Yao, M., Ren, T., Guo, W., Li, L., & Xu, X. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-54291-y · Cited by 11
Runesson, B., Xu, Y., Qureshi, A. R., Lindholm, B., Barany, P. F., Elinder, C. G., & Carrero, J. J. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14051 · Cited by 11
Xu, H., Zhang, Y., Xu, W., Chen, L., Zhang, M., Su, H., Cheng, Y., Zhao, N., Xu, D., & Qin, G. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.05.003 · Cited by 11
Cho, E.-H., Han, K., Kim, B., & Lee, D. H. (2020) · Medicine · doi:10.1097/md.0000000000021236 · Cited by 11
Nishihama, K., Eguchi, K., Maki, K., Okano, Y., Tanaka, S., Inoue, C., Uchida, A., Uemura, M., Suzuki, T., Yasuma, T., et al. (2021) · American Journal of Case Reports · doi:10.12659/ajcr.928090 · Cited by 11
Schroeder, E. B., Neugebauer, R. S., Reynolds, K., Schmittdiel, J. A., Loes, L., Dyer, W., Pimentel, N., DESAI, J. R., Vazquez‐Benitez, G., Ho, P. M., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.26605 · Cited by 11
Kifle, Z. D., Woldeyohanins, A. E., & Demeke, C. A. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100134 · Cited by 11
Scheen, A. J. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30042-0 · Cited by 12
Forni, A. A., Rocchio, M. A., Szumita, P. M., Anger, K. E., Avery, K. R., & Scirica, B. M. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.01.002 · Cited by 11
Clinical practice and implications of recent diabetes trials
Webster, M. W. I. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328347b139 · Cited by 11
Metadata
- Authors
- Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., Grobbee, D. E., Kengne, A. P., Marre, M., & Heller, S.
- Affiliations
- The University of Sydney (AU)
- University Medical Center Utrecht (NL)
- Hôpital Bichat-Claude-Bernard (FR)
- National Health Service (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1410-1418
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2097995302
- Semantic Scholar
- b73e51368b0f6c3d0c425e6670188db927bc8b09
- Cited by
- 1,471
- References
- 31
- Citations by year
- 2026: 33 · 2025: 49 · 2024: 64 · 2023: 60 · 2022: 66 · 2021: 103 · 2020: 119 · 2019: 99 · 2018: 113 · 2017: 103 · 2016: 107 · 2015: 147 · 2014: 106 · 2013: 98 · 2012: 103
- FWCI
- 71.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- severe hypoglycemia, type 2 diabetes, tight glycemic control, macrovascular events, cardiovascular mortality, all-cause mortality, adverse clinical outcomes, diabetes complications, UKPDS
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Gliclazide, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Risk Factors, Vascular Diseases, Proportional Hazards Models, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
